KEY PRODUCTS
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
01 1PANTOPRAZOLE SODIUM USP [PROCESS-2]
01 1India
01 1Active
01 1Complete
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-27
Pay. Date : 2020-03-23
DMF Number : 24813
Submission : 2011-03-31
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is PANTOPRAZOLE SODIUM USP [PROCESS-2], with a corresponding US DMF Number 24813.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 27, 2020, and payment made on March 23, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
